| Old Articles: <Older 14811-14820 Newer> |
 |
The Motley Fool June 7, 2006 Rich Smith |
Foolish Forecast: Nobility Homes The manufactured-homes builder is scheduled to report fiscal second-quarter 2006 earnings tomorrow giving investors a chance to take a closer look. Will it be a buy?  |
The Motley Fool June 7, 2006 Tim Beyers |
The First Step to $1 Million When it comes to investing, the first step to $1 million isn't to pick better stocks. It's to become an investing cheapskate. After you do that, investing is the easy part.  |
The Motley Fool June 7, 2006 Stephen D. Simpson |
American Woodmark on the Mark ... This Time Is this the beginning of better margins, or just another head-fake? This is a stock that has been unusually unstable, which operates in an increasingly nervous segment.  |
The Motley Fool June 7, 2006 Philip Durell |
Profit From a CEO Change A company is far more than the person at the top, yet the market routinely reacts wildly to a CEO change. Learn how to profit from this overreaction.  |
The Motley Fool June 7, 2006 Tim Beyers |
Cork the Champagne The stock market is loaded with common myths -- the so-called rules of thumb for when and how to invest. But really, do any of them work as advertised?  |
The Motley Fool June 7, 2006 Rich Smith |
Foolish Forecast: Shuffle Master The card-game equipment maker reports its fiscal second-quarter 2006 earnings results tomorrow. Investors, want to know what Wall Street expects to see? Want to know what really matters?  |
The Motley Fool June 7, 2006 Tom Taulli |
Alloy: Still No Luster Despite its dealings in the hot youth market, marketing-services company Alloy still can't make money. Investors, take note.  |
The Motley Fool June 7, 2006 Chuck Saletta |
Profit From Buyout Mania Earn premium payouts by investing in companies that invite buyouts.  |
The Motley Fool June 7, 2006 Stephen D. Simpson |
Cooper's Bleary Performance Missteps in strategy and operations for the contact lens company are coming home to roost. As is almost always the case with turnarounds, this is an idea with above-average risk, so don't make the mistake of underestimating the odds that things could get even worse.  |
The Motley Fool June 7, 2006 Stephen D. Simpson |
Novartis Can't Say No The Swiss drug giant signs more deals to boost its pipeline. Investors, here is a strong company in a weak sector that's still somewhat undervalued -- not exactly the worst story of the week.  |
| <Older 14811-14820 Newer> Return to current articles. |